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Purpose: This study examined a rapid isolation method decreasing the time and 
cost of the clinical application of adipose tissue-derived stem cells (ASCs).  Mate-
rials and Methods: Aliquots (10 g) of the lipoaspirates were stored at 4°C without 
supplying oxygen or nutrients. At the indicated time points, the yield of mononu-
clear cells was evaluated and the stem cell population was counted by colony 
forming unit-fibroblast assays. Cell surface markers, stem cell-related transcription 
factors, and differentiation potentials of ASCs were analyzed. Results: When the 
lipoaspirates were stored at 4°C, the total yield of mononuclear cells decreased, 
but the stem cell population was enriched. These ASCs expressed CD44, CD73, 
CD90, CD105, and HLA-ABC but not CD14, CD31, CD34, CD45, CD117, 
CD133, and HLA-DR. The number of ASCs increased 1×1014 fold for 120 days. 
ASCs differentiated into osteoblasts, adipocytes, muscle cells, or neuronal cells. 
Conclusion: ASCs isolated from lipoaspirates and stored for 24 hours at 4°C have 
similar properties to ASCs isolated from fresh lipoaspirates. Our results suggest 
that ASCs can be isolated with high frequency by optimal storage at 4°C for 24 
hours, and those ASCs are highly proliferative and multipotent, similar to ASCs 
isolated from fresh lipoaspirates. These ASCs can be useful for clinical application 
because they are time- and cost-efficient, and these cells maintain their stemness 
for a long time, like ASCs isolated from fresh lipoaspirates.
Key Words:    Lipoaspirates, adipose tissue, mesenchymal stem cell, proliferation, 
differentiation
INTRODUCTION
Mesenchymal stem cells (MSCs) have two properties; the ability to self-renew1,2 
and the ability to differentiate into multiple tissue type lineages, such as cartilage, 
bone, muscle, ligament, tendon, adipocytes and stromal cells.3-5 MSCs derived 
from bone marrow were first recognized by Friedenstein and co-workers,6-9 and 
many studies have since used bone marrow-derived stem cells (BMSCs). Recently, Young Woo Eom, et al.
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cal anesthesia. Local anesthetics such as articaine/epineph-
rine and lidocaine strongly impair preadipocyte viability.26 
Keck, et al. reported a marked influence of local anesthetics 
on not only the quantity but also the quality of viable preadi-
pocytes as determined by their ability to differentiate into 
mature adipocytes. 
In our procedures, lipoaspirates were extensively washed 
with phosphate-buffered saline (PBS) to remove contami-
nating blood cells and local anesthetics prior to preservation, 
and in order to exclude the effects of local anesthetics on 
the viability of preadypocytes and their differentiation into 
adipocytes. Therefore, in this study, we evaluated the optimal 
isolation conditions for ASCs from lipoaspirates stored at 
4°C without local anesthetic and a supply of oxygen and 
nutrients. Our results show that the numbers of mononucle-
ar cells gradually decreased during storage in a time depen-
dent manner, but that, in contrast, ASC isolation was en-
hanced when lipoaspirates were stored for 24 hours. 
MATERIALS AND METHODS
Isolation of adipose tissue-derived stem cells
Human adipose tissue was obtained from three healthy fe-
male donors with a mean age of 30.7±7.8 and body mass 
index of 23.7±3.7 at Park’s Cosmetic and Plastic Surgery 
(Seoul, Korea). The women underwent elective liposuction 
procedures under anesthesia according to procedures ap-
proved by the Institutional Review Board of Ajou Universi-
ty Hospital. Informed consent was obtained from all do-
nors. Mononuclear cells were isolated using a modified 
protocol described by Zuk, et al.21 In brief, lipoaspirates 
were extensively washed with PBS to remove contaminat-
ing blood cells and local anesthetics. Then, aliquots (10 g) 
of the washed lipoaspirates were preserved at 4°C without 
supplying oxygen or nutrients. At the indicated time points, 
an aliquot was enzymatically digested at 37°C for 40 min-
utes with 0.075% type IA collagenase (Sigma, St. Louis, 
MO, USA) in PBS. The red blood cell lysis step was omitted 
to reduce the isolation time because omission of this step 
caused no difference in yield of mononuclear cells and iso-
lation efficiency of mesenchymal stem cells. The digested 
lipoaspirates was centrifuged at 1,200 g for 5 minutes, and 
the pellet was resuspended and passed through a 100-μm 
mesh filter (Cell Strainer, Becton Dickinson, Franklin Lakes, 
NJ, USA) to remove debris. Cells were plated in 100-mm 
culture dishes at a density of 5×106 mononuclear cells with 
MSCs have been isolated from adipose tissue, umbilical 
cord blood, peripheral blood, brain, lung, liver, dermis, and 
skeletal muscle.10-18 MSCs reside in various tissues but can 
be isolated from bone marrow aspirates, adipose tissues, 
and the umbilical cord with 100% efficiency.19 Adipose tis-
sue can be obtained with less invasive procedures than oth-
er tissues. More importantly, adipose tissue-derived stem 
cells (ASCs) can be recovered in high quantities because 
adipose tissues are an abundant reservoir of MSC approxi-
mately >100-fold higher than bone marrow.20 Therefore, 
adipose tissue represents an abundant, practical, and ap-
pealing stem cell source for regenerative medicine.
ASCs are isolated using a combination of enzymatic di-
gestion with collagenase and methods that take advantage 
of their adherence properties.21 It was reported that 2-6×108 
mononuclear cells could be obtained from 300 mL of adi-
pose tissue.21 The average frequency of ASCs from lipoaspi-
rates was 0.1-1% of mononuclear cells, and the yield of ASCs 
was approximately 500-5,000 stem cells per 1 gram of adi-
pose tissue.20,22 Most research groups use the isolation meth-
od described by Zuk, et al.21 In brief, adipose tissue or li-
poaspirates are treated with collagenase immediately after 
surgical resection, and the mononuclear cells are plated in 
cell culture medium at a density of 5×106 mononuclear 
cells/100-mm culture dish. Subconfluent growth can be ob-
served within two weeks of initial plating. Therefore, to iso-
late ASCs from 300 mL of lipoaspirates, approximately one 
hundred 100-mm cell culture dishes are required. This la-
borious procedure can cause many problems, including cell 
contamination, increased costs and long isolation times. To 
improve ASC isolation procedures, we focused on the char-
acteristics of MSCs that were more resistant to unsuitable 
environments than other somatic cells.23,24 Mylotte, et al.24 
reported that MSCs were more resistant to ischemia than 
cardiomyocytes and that exposure to ischemia did not impair 
MSC differentiation potential. They further demonstrated 
that MSCs were resistant to hypoxia (0.5% O2) or inhibitory 
conditions of mitochondrial respiration with 2,4-dinitrophe-
nol for 72 hours. These results indicate that in the absence 
of oxygen, MSCs could survive using anaerobic ATP pro-
duction. Matsumoto, et al.25 reported that aspirated fat could 
be stored or transported overnight if preserved at 4°C and 
that adipose tissue-derived stem cell yield was not reduced 
by preservation at 4°C for one day, but they did not describe 
the effects of local anesthetics on the quantity and quality of 
viable preadipocytes. Generally, to obtain human lipoaspi-
rates, elective liposuction procedures are performed under lo-Stem Cell Enrichment by Preservation of Lipoaspirates
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ry antibodies. The fluorescence intensity of the cells was 
evaluated by flow cytometry (FC 500; Beckman Coulter) 
and the data were analyzed with the CXP software (Beck-
man Coulter).  
Differentiation assays
Adipogenic differentiation
Cells were plated at 2×104 cells/cm2 in 6-well plates and 
cultured for one week. The medium was then changed to an 
adipogenic medium [10% FBS, 1 μM dexamethasone, 0.5 
mM 3-isobutyl-1-methylxanthine, 10 μg/mL insulin and 100 
μM indomethacin in high glucose (HG)-DMEM] for an ad-
ditional three weeks. In order to determine adipogenic dif-
ferentiation, the cells were fixed in 4% paraformaldehyde 
for 10 minutes and stained with fresh Oil red-O solution 
(Sigma) to show lipid droplets in induced cells.27
Osteogenic differentiation
Cells were plated at 2×104 cells/cm2 in 6-well plates, then in-
duced in the following osteogenic medium for two to three 
weeks: low glucose (LG)-DMEM medium supplemented 
with 10% FBS, 10 mM β-glycerophosphate, 10-7 M dexa-
methasone, and 0.2 mM ascorbic acid (all from Sigma).28 In 
order to determine osteogenic differentiation, the release of 
p-nitrophenol from p-nitrophenyl phosphate by the ALP en-
zyme was observed.29 
Neuronal differentiation 
Cells were plated at 8×103 cells/cm2 in 6-well plates. After 
24 hours, the cells were preinduced for one day with HG-
DMEM supplemented with 20% FBS, and then the medi-
um was changed to neurogenic medium (200 μM BHA, 5 
mM KCl, 2 mM valproic acid, 10 μM forskolin, 1 μM hy-
drocortisone, 5 μg/mL insulin in serum-free HG-DMEM).30 
Neuron-specific genes were determined by RT-PCR and 
immunocytochemistry.
Myogenic differentiation 
Cells were plated at 1×103 cells/cm2 in 6-well plates. After 24 
hours, cells were preinduced for one day with LG-DMEM 
supplemented with 10% FBS, 3 μM 5-azacytidine, 10 ng/
mL fibroblast growth factor-2 (FGF-2), and 0.25 μg/mL 
amphotericin B. The medium was then changed to a myo-
genic medium (10% FBS and 10 ng/mL FGF-2 in LG-
DMEM)31,32 and muscle cell specific genes were determined 
by RT-PCR and immunoblotting as previously described.33
low glucose Dulbecco’s minimal essential medium (DMEM) 
containing 10% fetal bovine serum (FBS) and antibiotics 
(100 U/mL penicillin G and 100 μg/mL streptomycin). Af-
ter two days, the medium was changed to remove nonadher-
ent cells. The adhered cells were expanded for seven days, 
then trypsinized and counted. 
Culture and expansion 
ASCs were maintained in DMEM supplemented with 10% 
FBS and 1×penicillin/streptomycin (GibcoBRL, Rockville, 
MD, USA) in a humidified incubator at 37°C/5% CO2. The 
medium was changed twice weekly, and cells were pas-
saged with 0.25% trypsin/0.1% EDTA (GibcoBRL) upon 
reaching 90% confluency. Experiments for proliferation and 
differentiation were performed at passage 1 to 3. The num-
ber of population doublings was calculated using the follow-
ing formula: log N0/log N1, where N0 is the number of 
seeding cells and N1 is the number of recovered cells when 
they were passaged. Doubling time was determined by di-
viding the total number of hours in culture by the number of 
doublings.
CFU-F assay
For colony forming unit-fibroblast (CFU-F) assays, cells 
isolated from lipoaspirates were seeded at 5,000 cells/well 
in triplicated 6-well plates and fed twice weekly for two 
weeks. For direct visualization of the colonies, the cells 
were washed with PBS and fixed in 95% ethanol for five 
minutes, and then the cells were incubated for 30 minutes 
at room temperature in 0.5% crystal violet in 95% ethanol. 
Excess stain was removed by washing with distilled H2O. 
The plates were dried and the CFU-F units counted. We de-
fined a CFU-F unit as consisting of more than 100 cells us-
ing a microscope.
Immunophenotype analysis 
ASCs were stained with combinations of saturating amounts 
of antibodies conjugated with fluorescein isothiocyanate 
(FITC) or phycoerythrin (PE): CD14-FITC, CD31-PE, 
CD34-PE, CD44-FITC, CD45-FITC, CD73-PE, CD90-
FITC, CD117-PE, CD133-PE, HLA-ABC-FITC, HLA-DR-
PE (BD Biosciences, San Jose, CA, USA), and CD105-PE 
(Ancell, Bayport, MN, USA). A total of 5×105 cells were 
resuspended in 0.2 mL PBS and incubated with FITC- or 
PE-conjugated antibodies for 20 minutes at room tempera-
ture. FITC- or PE-conjugated mouse IgGs were used as the 
control isotype at the same concentration as specific prima-Young Woo Eom, et al.
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observed and photographed under a fluorescent microscope 
(IX-71, Olympus, Shinjuku-ku, Tokyo, Japan).
RT-PCR
Total RNA was extracted from the cells using the TRIzol Re-
agent (GibcoBRL, Rockville, MD, USA). A total of 2 μg of 
RNA was reverse-transcribed with AMV reverse transcrip-
tase XL (TaKaRa, Otsu, Shiga, Japan) for one hour at 42°C 
in the presence of oligo-dT primer. PCR was performed us-
ing Taq DNA polymerase (BioQuest, Seoul, Korea). Ampli-
fied products were electrophoresed on a 2% agarose gel and 
photographed under an ultraviolet light transilluminator (Bio-
Rad, Hercules, CA, USA). The sequences of oligonucleotide 
primers used for RT-PCR and the expected transcript sizes 
are listed in Table 1. 
Statistical analysis
Data are expressed as mean±standard deviation. Statistical 
significance was estimated by the Student’s t-test and a paired 
t-test. Significance was defined as p-value of  ≤0.05. 
RESULTS
 
Yield of mononuclear cells by processing time
The lipoaspirates were extensively washed with phosphate-
buffered saline (PBS) to remove contaminating blood cells 
and local anesthetics, and then aliquots (10 g) of the washed 
lipoaspirates were stored at 4°C until needed. An aliquot of 
lipoaspirates was digested with type IA collagenase after a 
total storage period of between 3 and 36 hours, and the re-
covered mononuclear cells were counted. Interestingly, al-
though the total yield of mononuclear cells from preserved li-
poaspirates gradually decreased from 3.06×106 cells/g at 
three hours post-storage to 0.4×106 cells/g at 36 hours post-
storage (Fig. 1A), that of CFU-F and expanded cells during 
Immunoblotting
The cells were washed with ice-cold DPBS and lysed in 
RIPA buffer [50 mM Tris-HCl, pH 7.5, containing 1% Triton 
X-100, 150 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), 
and 1% sodium deoxycholate] with a protease inhibitor 
cocktail (Sigma, St. Louis, MO, USA) on ice. The lysate was 
centrifuged at 13,000 g for 10 min at 4°C. The supernatant 
was transferred to a new tube, and its protein concentration 
was measured by using a protein assay kit (Bio-Rad, Hercu-
les, CA, USA). 30 μg proteins were resolved by 10% SDS 
reducing gel and elcctrophoretically transferred onto polyvi-
nylidene difluoride membranes (Amersham Pharmacia Bio-
tech, Buckinghamshire, UK) using a trans-blot system (Bio-
Rad, Hercules, CA, USA). Blots were probed using anti-
actin (1 : 1000 dilution; Santa Cruz Biotech, Santa Cruz, CA, 
USA), anti-myogenin (1 : 1000 dilution; Santa Cruz Biotech, 
CA, USA), and anti-MyHC (1 : 1000 dilution; Santa Cruz 
Biotech, CA, USA). The next day, bound primary antibodies 
were detected with horseradish peroxidase-conjugated sec-
ondary antibodies (1 : 2000 dilution; Santa Cruz Biotech, 
CA, USA), and visualized with an enhanced chemilumines-
cence detection system (Amersham Pharmacia Biotech, 
Buckinghamshire, UK).
Immunocytochemistry
The cells were fixed in 10% formalin solution (Sigma), per-
meabilized with 0.2% Triton X-100 in PBS for 5 min at 
room temperature, and blocked with 2% FBS in PBS for 30 
min at room temperature. They were incubated with a pri-
mary antibody specific to NF-L (1 : 100 dilution; Santa 
Cruz Biotech, CA, USA) for 4°C overnight, and then la-
beled with rhodamine-conjugated secondary antibodies (1 : 
100, Santa Cruz Biotech) for 1 h at room temperature after 
primary incubation. The cells were also stained with 1 μg/
mL 4’, 6-diamino-2-phenylindole (DAPI, Sigma, St. Louis, 
MO, USA) in order to visualize their nuclei. The slides were 
Table 1. RT-PCR Primers for Validation of Gene Expression 
Forward primer (5’-3’) Reverse primer (5’-3’) Product size, bp
GAPDH CAAGGCTGAGAACGGGAAGC AGGGGGCAGAGATGATGACC 194
MyoD AATGTAGCAGGTGTAACCGT GCCTTTATTTTGATCACCTG 230
Myogenin CACTACTTCTGTAGCAGGGG TCTCTCAAACCGTTTCACTT 305
Dystrophin CAGTAGCCCCATCACATTTG ATAACGCAATGGACAAGTGG 566
MCK GGCACAATGACAACAAGAGC GAAAAGAAGAGGACCCTGCC 721
NeuroD TGACCAAATCGTACAGCGAGAG AGAAGTTGCCATTGATGCTGAGCG 848
NF-L ACCCGACTCAGTTTCACCAG TCAGCCTTAGACGCCTCAAT 200
Nestin GCCCTGACCACTCCAGTTTA GGAGTCCTGGATTTCCTTCC 200
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MyoD, class I myosin; MCK, muscle creatine kinase; NeuroD, neurogenic differ-
entiation; NF-L, neurofilament light polypeptide.  Stem Cell Enrichment by Preservation of Lipoaspirates
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Proliferation capacity 
In order to examine the in vitro proliferative potential of 
ASCs isolated from an aliquot preserved for 24 hours at 4°C, 
we replated the cells at 1,000 cells/cm2 every 8-10 days until 
their initial population doubling (PD) time increased by more 
than three times. The proliferative potential was retained 
even at passage 12 (Fig. 3), and cell numbers increased 
1×1014 fold. The population doubling time at early passages 
was maintained from about 39 to 50 hours until passage 6, 
and then gradually increased until passage 12. The PD times 
of passages 12 and 13 were 104 and 175 hours, respectively. 
Differentiation capacity 
Previous studies have demonstrated the osteogenic, chon-
drogenic, adipogenic, myogenic, cardiomyogenic, and neu-
rogenic potential of ASCs. In order to examine the differen-
tiation potentials of ASCs isolated from an aliquot 
preserved for 24 hours at 4°C, osteogenic, adipogenic, 
myogenic, or neurogenic differentiation of ASCs was in-
duced. In Fig. 4, alkaline phosphatase activity, a marker of 
seven days peaked from aliquots preserved for 24 hours (Fig. 
1B and C). The ability of mononuclear cells isolated from an 
aliquot preserved for 24 hours (yield of 2.8±0.08%) to form a 
CFU-F unit was -4.7 times higher than those stored for only 
three hours (yield of 0.6±0.2%). Also, the expanded cell 
number after seven days was 3.9 times higher in the aliquots 
that were preserved for 24 hours. 
Cell surface markers 
In order to characterize the surface phenotype of ASCs iso-
lated from an aliquot preserved for 24 hours, cell surface 
markers were examined at the third passage. Flow cytomet-
ric results showed that ASCs isolated after preservation for 
24 hours were positive for CD44, CD90, CD73, CD105, and 
HLA-ABC. In addition, expression of CD14, CD31, CD34, 
CD45, CD117, CD133, and HLA-DR was not observed 
(Fig. 2). This phenotype is similar to the phenotype of stem 
cells isolated from the bone marrow, umbilical-cord blood, 
and umbilical cord tissue.34 It is also consistent with the 
ASC phenotype reported by Gronthos and Zuk.35,36
Fig. 1. Isolation of ASCs from lipoaspirates preserved at 4°C. (A) Yields of mononuclear cells isolated from lipoaspirates. Mononuclear 
cells were isolated from lipoaspirates preserved at 4°C for the indicated times as described in the Materials and Methods section, and 
then viable mononuclear cells were counted by staining with trypan blue. (B) Recovery of cells at day 7. Each set of mononuclear cells 
was isolated at the indicated times and cultured in 100-mm culture dishes at a density of 5×10
6 cells. On day 7, the expanded cells were 
counted. (C) Clonogenic ability of mononuclear cells isolated from lipoaspirates. Five thousand mononuclear cells were plated in 6-well 
plates. They were cultured for two weeks, and then colony forming unit-fibroblasts (CFU-F) were stained with crystal violet. A colony 
consisting of more than 100 cells was counted microscopically. Representative histograms of three independent experiments are shown, 
and error bars represent the standard deviation. ASCs, adipose tissue-derived stem cells.
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etal muscle cells (MyoD, Myogenin, dystrophin, MCK, and 
MyHC) or neuronal cells (neuroD, NF-L, nestin) were ex-
pressed in mRNA (Fig. 4C and E) and protein levels (Fig. 
4D and F). 
osteogenesis, was detected at high levels (Fig. 4A), and Oil-
Red-O stain accumulated in intracellular lipid-filled droplets 
of adipocytes differentiated from ASCs (Fig. 4B). In myo-
genic or neurogenic differentiation of ASCs, markers of skel-
Fig. 2. Expression of cell surface markers of ASCs isolated from lipoaspirates preserved for 24 hours. Expression of cell surface markers of 
ASCs isolated from lipoaspirates preserved for 24 hours was determined by flow cytometry as described in the Materials and Methods sec-
tion. CD14-FITC and CD105-PE, CD44-FITC and CD133-FITC, CD45-FITC and CD34-PE, and HLA-ABC-FITC and HLA-DR-PE were double stained. 
ASCs, adipose tissue-derived stem cells; FITC, fluorescein isothiocyanate; PE, phycoerythrin.
Fig. 3. Proliferation potentials of ASCs isolated from lipoaspirates preserved for 24 hours. ASCs were cultured in 6-well plates at a density of 
1000 cells/cm
2. When the cells grew confluent, the total cell numbers were counted and then re-cultured at the same density. These pro-
cedures were repeated until cell growth stopped. Numbers of cells (-■-) and population doubling times (histogram) were represented at 
each passage. Representative histograms of three independent experiments are shown, and error bars represent the standard deviation. 
ASCs, adipose tissue-derived stem cells.
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duced time required for isolation and the increased yield of 
stem cells might be the results of enrichment by increased 
storage time and the resistance of stem cells to environments 
unsuitable for somatic cells. In fact, Mylotte, et al.24 report-
ed that MSCs were more resistant to unsuitable environ-
ments, such as ischemia, hypoxia (0.5% O2), and the inhibi-
tory conditions of mitochondrial respiration. These results 
highlighted the fact that mesenchymal stem cells from li-
poaspirates could be enriched by an unsuitable environment 
such as cold preservation without oxygen or nutrients.    
In order to gain the optimal therapeutic effects of stem 
cell for clinical application, some issues must be considered 
carefully. First, stemness, as evaluated by proliferation and 
differentiation potentials, must be maintained during ex vivo 
expansion of stem cells. It is well established that the stem-
ness of stem cells is gradually lost after prolonged cell cul-
ture and, thus, that maintenance of stemness may play a 
pivotal role in the regeneration of damaged cells or tissues. 
DISCUSSION
   
We report an optimal ASC isolation method that reduces 
cell contamination or cost and time required by preserving 
lipoaspirates at 4°C for 24 hours. We carefully evaluated 
the phenotype, proliferation and differentiation potentials of 
ASCs isolated from lipoaspirates preserved at 4°C for 24 
hours, and our results are in agreement with previous re-
ports34-37 that state that the phenotype of ASCs isolated from 
lipoaspirates preserved at 4°C for 24 hours was similar to 
that of ASCs isolated immediately after surgery or BMSC. 
In fact, although we directly compared the characteristics of 
stem cells isolated at 3- and 24-hour time points from eight 
donors, we found no differences (data not shown). Our pro-
cedure reduced the required time for isolating stem cells 
from about 14 to 7 days and increased the total yield of 
stem cells from adipose tissue. We suggest that of the re-
Fig. 4. Differentiation potentials of ASCs isolated from lipoaspirates preserved for 24 hours. Passage 1 cells were seeded and differentiat-
ed into adipocytes, osteoblasts, muscle cells, or neuronal cells as described in the Materials and Methods section. Osteogenic (A) or ad-
ipogenic differentiation (B) were evaluated by assaying the alkaline phosphatase activity or Oil-Red O staining, respectively. To evaluate 
differentiation potentials of ASCs into muscle (C and D) or neuronal cells (E and F), we investigated the expression of several markers 
(myogenic; MyoD, Myogenin, Dystrophin, MCK and neurogenic; NeuroD, NF-L, Nestin) by RT-PCR, immunoblotting (myogenic; Myogenin 
and MyHC), and immucocytochemistry (neurogenic; NF-L). ASCs, adipose tissue-derived stem cells; MyoD, class I myosin; MCK, muscle 
creatine kinase; NeuroD, neurogenic differentiation; NF-L, neurofilament light polypeptide; DAPI, 4’, 6-diamino-2-phenylindole; MyHC, 
myosin heavy chain.
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In our results, PD time of ASCs isolated from lipoaspirates 
preserved at 4°C for 24 hours was below 75 hours up to 
passage 11. Further, expression of stemness-related tran-
scription factors, Klf4, Nanog, Sox2, and Oct4 was not de-
creased (data not shown). Taken together, ASCs isolated by 
our protocols were able to expand sufficiently for a relatively 
long time in culture without loss of stemness. Second, abun-
dant quantities of stem cells are required for clinical trials. 
To obtain sufficient stem cells within a short period of time, it 
is important that stem cell sources have high reservoirs of 
stem cells. In addition, these stem cells must be isolated as 
rapidly as possible. Therefore, if MSCs were isolated rapidly 
from adipose tissue using our procedure in numbers approxi-
mately 100+ fold than from bone marrow,20 ASCs may pro-
vide the best stem cells for clinical trials. 
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